This webinar provides information about RFA-CA-25-009 “Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT) Lung Cancer Screening (UG3/UH3 Clinical Trial Required)” and RFA-CA-010 “Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT) Tobacco Use Treatment for Cancer Survivors (UG3/UH3 Clinical Trial Required)”. The Lung Cancer Screening funding opportunity aims to advance the science of scaling-up and sustaining the delivery of lung cancer screening for populations at high-risk for lung cancer. The Tobacco Use Treatment for Cancer Survivors funding opportunity aims to advance the science of scaling-up and sustaining the delivery of tobacco use treatment services for cancer survivors.
NCI staff provides an overview of the funding opportunity and application process and addresses general questions.
Reasonable Accommodations
Closed captioning will be available to all participants. Individuals who need reasonable accommodations to participate should contact NCIdccpsISteam@mail.nih.gov. Requests should be made at least five business days in advance of the event
Speakers
Program Director
Implementation Science
Division of Cancer Control and Population Sciences
Senior Advisor
Implementation Science
Division of Cancer Control and Population Sciences